Upgrade to SI Premium - Free Trial

Nautilus Biotechnology (NAUT)

2.68 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/4/26)

Latest Headlines

Form SCHEDULE 13D/A Nautilus Biotechnology, Filed by: AH Bio Fund II, L.P. June 4, 2026 4:55 PM - SEC Filing Form 4 Nautilus Biotechnology, For: Jun 02 Filed by: Andreessen Marc L June 4, 2026 4:54 PM - SEC Filing Form ARS Nautilus Biotechnology, For: Dec 31 April 28, 2026 4:12 PM - SEC Filing Form DEFA14A Nautilus Biotechnology, April 28, 2026 4:10 PM - SEC Filing Form DEF 14A Nautilus Biotechnology, For: Jun 17 April 28, 2026 4:10 PM - SEC Filing Form 10-Q Nautilus Biotechnology, For: Mar 31 April 28, 2026 4:09 PM - SEC Filing Nautilus Biotechnology, Inc. (NAUT) Tops Q1 EPS by 5c April 28, 2026 8:00 AM - StreetInsider Nautilus Biotechnology Reports First Quarter 2026 Financial Results April 28, 2026 8:00 AM - Globe NewsWire Form 8-K Nautilus Biotechnology, For: Apr 28 April 28, 2026 6:07 AM - SEC Filing Nautilus Biotechnology to Announce First Quarter 2026 Financial Results on April 28, 2026 April 9, 2026 8:00 AM - Globe NewsWire Q1 Virtual Investor Summit Presentations Now Available On Demand March 26, 2026 3:48 PM - StreetInsider Investor Summit Announces Q1 Presenter Line Up (Presentations 3/25, 1-on-1s 3/26) March 20, 2026 8:00 AM - StreetInsider Nautilus Biotechnology Announces Baylor College of Medicine as First Early Access Program Customer for Voyager Platform March 18, 2026 8:00 AM - StreetInsider Full Article List